Abstract
Patients with implantable cardioverter/defibrillators (ICD) suffer frequent and various complications during follow-up1. Within a recent multicenter study including 820 patients with a third-generation ICD, 280 patients (34%) experienced adverse events within a follow-up of only 5 ± 5 months2. Thus, a close follow-up of these patients by a physician aware of typical complications should be warranted. The most common adverse event is inappropriate arrhythmia detection typically resolved by programming or drug changes3. Other adverse events which might be resolved by reprogramming are syncopes despite ICD therapy4, ventricular tachycardias below the programmed detection rate5, and painful cardioversion shocks delivered during haemodynamically tolerated ventricular tachycardias6. Further complications, such as infection of the ICD, lead dis-lodgements, insulation failures, lead perforation, and emboli from thrombi attached to the leads which might be detected during follow-up, frequently require surgical intervention1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Block M, Hammel D, Bänsch D et al. Prevention of ICD complications. In: Allessie M, Fromer M, editors. Atrial and Ventricular Fibrillation — mechanisms and device therapy. Armonk, NY: Futura; 1997: 291–309.
Rosenquist M, Beyer T, Beyer M, den Dulk K, Minten J, for the European Jewel Investigators. Adverse events in patients with implantable cardioverter defibrillators — a prospective study. PACE 1996; 19: 715 (abstract).
Weber M, Block M, Brunn J et al. Inappropriate ICD-therapies — incidence, causes, risk factors and prevention. Z Kardiol 1996; 85: 809–19.
Bänsch D, Brunn J, Castrucci M et al. Syncopes in patients with implantable cardioverter defibrillators: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 1998 (In press).
Castrucci M, Block M, Bänsch D, Weber M, Böcker D, Breithardt G. Significance of ventricular tachycardias below the programmed tachycardia detection interval in patients with implantable cardioverter defibrillators. Eur Heart J 1997; 18 (Suppl.) 644 (abstract).
Stankoweit B, Muthny FA, Block M, Breithardt G. Quality of life after implantation of an implantable cardioverter defibrillator (ICD)-empirical results from 132 patients. Z Kardiol 1997; 86: 460–8.
Mirowski M, Reid PR, Mower MM et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322–4.
Reid PR, Mirowski M, Mower MM et al. Clinical evaluation of the internal automatic cardioverter defibrillator in survivors of sudden cardiac death. Am J Cardiol 1983; 51: 1608–13.
Chapman PD, Troup P. The automatic implantable cardioverter-defibrillator: evaluating suspected inappropriate shocks. J Am Coll Cardiol 1986; 7: 1075–8.
McVeigh K, Mower MM, Nisam S, Voshage L. Clinical efficacy of low energy cardioversion in automatic implantable cardioverter defibrillator patients. PACE 1991; 14: 1846–9.
Block M, Breithardt G. Long-term follow-up and clinical results of implantable cardioverter defibrillators. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: from cell to bedside. Philadelphia: WB Saunders; 1995: 1412–25.
Bakker PFA, Hauer RNW, Weyer EFD. Infections involving implanted cardioverter defibrillator devices. PACE 1992; 15: 654–8.
Gold MR, Peters RW, Johnson JW, Shorofsky SR, for the World-Wide Jewel Investigators. Complications associated with pectoral implantation of cardioverter defibrillators. PACE 1997; 20: 208–11.
Seifert T, Fastenrath C, Castrucci M et al. Akutes Abdomen durch Perforation eines automatischen implantierbaren Kardioverter-Defibrillators in die freie Bauchhöhle. Herzschr Elektrophys 1993; 4: 133–6.
Auricchio A, Hartung W, Geller C, Klein H. Clinical relevance of stored electrograms for implantable cardioverter-defibrillator (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias. Am J Cardiol 1996; 78 (Suppl. 5A): 33–41.
Marchlinski FE, Callans DJ, Gottlieb CD, Schwartzman D, Preminger M. Benefits and lessons learned from stored electrograms information. J Cardiovasc Electrophysiol 1995; 6: 832–51.
Lavergne T, Daubert JC, Chauvin M et al. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. PACE 1997; 20: 182–8.
Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996; 7: 542–58.
Mewis C, Kühlkamp V, Dörnberger V, Mermi J, Seipel L. High incidence of isolator fractures in trans-venous implanted cardioverter/defibrillators. Z Kardiol 1997; 86: 85–94.
Neuzner J, Pitschner HF, Schlepper M. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy. PACE 1995; 18: 539–47.
Schaumann A, von zur Mühlen F, Gonska BD, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiol 1996; 78 (Suppl. 5A): 42–50.
Jones G, Bardy G, Kudenchuk P et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J 1995; 130: 327–33.
Seifert T, Block M, Hammel D et al. Right ventricular perforation by transvenous electrodes of implantable cardioverter-defibrillators. PACE 1996; 19: 677 (abstract).
Jung W, Fehske W, Manz M et al. Randomized comparison of aspirin and phenprocoumon for prevention of right-sided thromboembolic complications associated with transvenous defibrillation leads. Eur Heart J 1995; 16: 986–92.
Brunn J, Block M, Weber M et al. Value of testing the defibrillation functions of ICDs. Z Kardiol 1997; 86: 450–9.
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures) in collaboration with the North American Society of Pacing and Electrophysiology: Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. J Am Coll Cardiol 1995; 26: 555–73.
Goldberger JJ, Horvath G, Inbar S, Kadish AH. Utility of predischarge and one-month transvenous implantable defibrillator tests. Am J Cardiol 1997; 79: 822–6.
Schaumann A, Meyer O, Dorszewski A, Kreuzer H, Gonska BD. A prospective study of tested versus nontested antitachycardia pacing in implantable cardioverter-defibrillators. PACE 1995; 18: 898 (abstract).
Andresen D, Block M, Borggrefe M et al. Empfehlungen zur Implantation von Defibrillatoren. Z Kardiol 1994; 83: 242–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Block, M., Lamp, B., Weber, M., Breithardt, G. (1998). Follow-Up Techniques in Patients with Implantable Cardioverter/Defibrillators. In: Vardas, P.E. (eds) Cardiac Arrhythmias, Pacing & Electrophysiology. Developments in Cardiovascular Medicine, vol 201. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5254-9_45
Download citation
DOI: https://doi.org/10.1007/978-94-011-5254-9_45
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6210-7
Online ISBN: 978-94-011-5254-9
eBook Packages: Springer Book Archive